Adjuvant endocrine therapy in premenopausal women with breast cancer

By González Martín Antonio   Cruz Susana   Márquez Raúl  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-09 ,pp. : 43-47

Springer Publishing Company

Access to resources Recommend Favorite

Efficacy of goserelin plus anastrozole in premenopausal women with advanced or recurrent breast cancer refractory to an LH-RH analogue with tamoxifen: Results of the JMTO BC08-01 phase II trial

By                      

Oncology Reports, Vol. 29, Iss. 5, 2013-01 ,pp. : 1707-1713

Spandidos Publications

Access to resources Recommend Favorite

Letrozole as Primary Medical Therapy for Locally Advanced and Large Operable Breast Cancer

By Dixon J.M.  

Breast Cancer Research and Treatment, Vol. 66, Iss. 3, 2001-04 ,pp. : 191-199

Springer Publishing Company

Access to resources Recommend Favorite

Adjuvant!^© Online estimation of chemotherapy effectiveness when added to ovarian function suppression plus tamoxifen for premenopausal women with estrogen-receptor-positive breast cancer

By Paridaens Robert   Gelber Shari   Cole Bernard   Gelber Richard   Thürlimann Beat   Price Karen   Holmberg Stig   Crivellari Diana   Coates Alan   Goldhirsch Aron  

Breast Cancer Research and Treatment, Vol. 123, Iss. 1, 2010-08 ,pp. : 303-310

Springer Publishing Company

Access to resources Recommend Favorite

The use of gonadotrophin-releasing hormone (GnRH) agonists in early and advanced breast cancer in pre- and perimenopausal women

By Robertson J.F.R.   Blamey R.W.  

European Journal of Cancer, Vol. 39, Iss. 7, 2003-05 ,pp. : 861-869

Elsevier

Access to resources Recommend Favorite